Clustering data with hclust algorithm for Effects of NO Donor Therapy on the Dystrophic Mouse Muscle TCA Cycle (part VI) (Study ST000650)
GC POSITIVE ION MODE (Analysis AN000982)| Metabolite | Structure | F1 | F2 | F3 | F4 | F5 | F6 |
|---|---|---|---|---|---|---|---|
| Ketoglutarate | ME175546 | 0.53 | 0.42 | 0.47 | 3.65 | 0.41 | 0.53 |
| Lactate | ME175542 | 1.02 | 0.94 | 0.96 | 0.94 | 1.16 | 0.98 |
| Oxaloacetate | ME175545 | 1.01 | 0.78 | 1.26 | 0.85 | 1.03 | 1.07 |
| 2-Hydroxyglutarate | ME175548 | 1.00 | 1.00 | 1.14 | 1.14 | 0.76 | 0.97 |
| cis-Aconitic Acid | ME175549 | 1.02 | 1.01 | 1.11 | 1.05 | 0.81 | 1.00 |
| Citrate | ME175550 | 1.09 | 1.07 | 1.10 | 0.91 | 0.83 | 1.00 |
| Fumarate | ME175544 | 1.14 | 1.11 | 1.06 | 0.85 | 0.91 | 0.94 |
| Malate | ME175547 | 1.14 | 1.12 | 1.04 | 0.85 | 0.91 | 0.94 |
| Isocitrate | ME175551 | 1.09 | 0.86 | 0.87 | 1.25 | 0.95 | 0.98 |
| Succinate | ME175543 | 1.30 | 0.85 | 0.98 | 1.04 | 0.89 | 0.94 |
Factors:
| F1 | Time point:Post Run | Grouping:RUN-Naproxcinod |
| F2 | Time point:Post Run | Grouping:RUN-Naproxen |
| F3 | Time point:Post Run | Grouping:RUN-Vehicle |
| F4 | Time point:Sedentary | Grouping:SED-Naproxcinod |
| F5 | Time point:Sedentary | Grouping:SED-Naproxen |
| F6 | Time point:Sedentary | Grouping:SED-Vehicle |
